Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 6/16/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Howard Rosen?

Howard M. Rosen

Sales Representative

Boston Scientific Corporation

HQ Phone:  (508) 683-4000

Direct Phone: (508) ***-****direct phone

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Boston Scientific Corporation

300 Boston Scientific Way

Marlborough, Massachusetts,01752

United States

Company Description

Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader for more than 35 years, we advance science for life by providing a broad range of high performan...more

Background Information

Employment History

Vice President, Cell Processing

Haemonetics Corporation


Vice President of Marketing and Business Development

Intact Vascular Inc


Vice President, Sales and Marketing

BG Medicine Inc


Web References(9 Total References)


Intact Vascular, Developer of the Tack Endovascular System

www.intactvascular.com [cached]

Howard Rosen
Vice President of Marketing & Business Development photo Howard Rosen Howard Rosen Vice President of Marketing & Business Development Mr. Howard Rosen has more than 25 years of commercial experience in sales, upstream and downstream marketing, market development and business unit general management across multiple cardiovascular market segments. He joined Intact Vascular in 2017 and will lead the company's efforts to prepare for commercialization of its Tack Endovascular System® for the repair of dissections following peripheral artery angioplasty. Prior to joining Intact Vascular, Mr. Rosen's career included twenty-one years at Boston Scientific Corporation, where he began his career as a sales representative and rose through the marketing ranks to hold positions of increasing responsibility in the peripheral vascular interventions and cardiovascular businesses. Mr. Rosen most recently served as Vice President of the Cell Processing Franchise at the Haemonetics Corporation. Mr. Rosen holds a B.S. in Business Administration from Northeastern University.


Management | BG Medicine Corporate Site

investor.bg-medicine.com [cached]

Howard Rosen
Vice President, Sales and Marketing Mr. Rosen joins BG Medicine from a two decade tenure in Sales and Marketing with Boston Scientific, where he most recently held the position of Director, Cardiovascular Service Line Franchise in the Cardiology, Rhythm and Vascular (CRV) Division where he led marketing strategies and channel activities. Previously at Boston Scientific, he held positions of increasing responsibility, including sales, product management, Group Marketing Manager, Director, and Global Carotid Endovascular Therapies for the Medi-tech and Peripheral Vascular Divisions. Prior to Boston Scientific, Mr. Rosen held sales and product management roles with Medi-tech. Mr. Rosen holds a B.S. in Business Administration from Northeastern University.


www.galectin-3.com

Howard Rosen
Vice President, Sales and Marketing Howard Rosen Vice President, Sales and Marketing Mr. Rosen joins BG Medicine from a two decade tenure in Sales and Marketing with Boston Scientific, where he most recently held the position of Director, Cardiovascular Service Line Franchise in the Cardiology, Rhythm and Vascular (CRV) Division where he led marketing strategies and channel activities. Previously at Boston Scientific, he held positions of increasing responsibility, including sales, product management, Group Marketing Manager, Director, and Global Carotid Endovascular Therapies for the Medi-tech and Peripheral Vascular Divisions. Prior to Boston Scientific, Mr. Rosen held sales and product management roles with Medi-tech. Mr. Rosen holds a B.S. in Business Administration from Northeastern University.


Intact Vascular Adds Howard Rosen to its Executive Management Team as VP Marketing and Business Development

www.intactvascular.com [cached]

May 1, 2017 - WAYNE, Pa.--(BUSINESS WIRE)--Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that Howard Rosen has joined its executive management team as Vice President of Marketing and Business Development.
In this position, Mr. Rosen will lead the company's efforts to prepare for commercialization of its Tack Endovascular System® for the repair of dissections following peripheral artery angioplasty. "Howard brings deep experience in both upstream and downstream marketing, as well as first-hand knowledge of the peripheral vascular marketplace and our customers," said Bruce J. Shook, Intact Vascular's President and CEO. "Howard is a welcome addition to our team as we move through the Pre-Market Approval (PMA) application process and toward market introduction of our products," Shook continued. Prior to joining Intact Vascular, Mr. Rosen's career included twenty-one years at Boston Scientific Corporation (NYSE: BSX), where he began his career as a sales representative and rose through the marketing ranks to hold positions of increasing responsibility in the peripheral vascular interventions and cardiovascular businesses. Mr. Rosen most recently served as Vice President of the Cell Processing Franchise at the Haemonetics Corporation (NYSE: HAE). "Intact Vascular has created a novel solution to the widespread problem of dissections following angioplasty, and the company has made a significant investment in clinical research. I am excited to build on that strong foundation and bring this important technology to clinicians and their patients," said Mr. Rosen.


Intact Vascular Adds Howard Rosen to its Executive Management Team as VP Marketing and Business Development | Business Wire

www.businesswire.com [cached]

WAYNE, Pa.--(BUSINESS WIRE)--Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that Howard Rosen has joined its executive management team as Vice President of Marketing and Business Development.
In this position, Mr. Rosen will lead the company's efforts to prepare for commercialization of its Tack Endovascular System for the repair of dissections following peripheral artery angioplasty. "Howard brings deep experience in both upstream and downstream marketing, as well as first-hand knowledge of the peripheral vascular marketplace and our customers," said Bruce J. Shook, Intact Vascular's President and CEO. "Howard is a welcome addition to our team as we move through the Pre-Market Approval (PMA) application process and toward market introduction of our products," Shook continued. Prior to joining Intact Vascular, Mr. Rosen's career included twenty-one years at Boston Scientific Corporation (NYSE: BSX), where he began his career as a sales representative and rose through the marketing ranks to hold positions of increasing responsibility in the peripheral vascular interventions and cardiovascular businesses. Mr. Rosen most recently served as Vice President of the Cell Processing Franchise at the Haemonetics Corporation (NYSE: HAE). "Intact Vascular has created a novel solution to the widespread problem of dissections following angioplasty, and the company has made a significant investment in clinical research. I am excited to build on that strong foundation and bring this important technology to clinicians and their patients," said Mr. Rosen.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory